Westchester Capital Management (New York)’s Alder Biopharmaceuticals ALDR Stock Holding History

Westchester Capital Management (New York)’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-733,600	Closed	-$13.8M	–	192
2019 Q3	$13.8M	Buy	+733,600	New	+$8.39M	0.54%	34

Westchester Capital Management (New York)'s ALDR Position: Q4 2019 in Review

Westchester Capital Management (New York) sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 733,600 shares — an estimated $13.8M sold.

Westchester Capital Management (New York) first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $13.8M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Westchester Capital Management (New York) reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Westchester Capital Management (New York) sold 733,600 Alder Biopharmaceuticals shares in Q4 2019, an estimated $13.8M.
Westchester Capital Management (New York) first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
Westchester Capital Management (New York)'s Alder Biopharmaceuticals position peaked at $13.8M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2019, filed 14 Feb 2020.